Julia Rossie

Dr. Julia Rossié

Baker McKenzie Rechtsanwaltsgesellschaft mbH von Rechtsanwälten und Steuerberatern


Dr. Julia Rossié is an associate in the Corporate/M&A Practice Group in Munich. Prior to joining the Firm in 2018, Julia gained experience in the areas of corporate law, restructuring and litigation by working as a law clerk in international law firms and companies. During her legal clerkship, Julia also worked for the German Federal Ministry of the Interior and the German Federal Foreign Office. Her doctoral thesis focuses on corporate law and reorganisational measures.

Practice Focus

Julia advises domestic and international clients on a wide range of corporate matters. She focuses her practice on domestic and cross-border M&A transactions, private equity, corporate structures, employee participation and reorganizations. Julia advises particularly in the life sciences field.

Representative Legal Matters

  • Advised CatalYm GmbH, an innovative biotech company developing novel cancer immunotherapies, on the closing of its EUR 50 million Series B equity financing. 
  • Advised AURELIUS Equity Opportunities SE & Co. KGaA on the sale of its subsidiary GHOTEL hotel & living to the Cologne-based Art-Invest Real Estate Group.
  • Advised Parkmobile Group Holding B.V., a provider of cashless parking payment solutions and related services, on its acquisition of all shares in Berlin based Parkling GmbH, a provider of on-street mobility services.
  • Advised the German biotech company MODAG on the in-licensing of an innovative substance portfolio (SERY 433) from Max Planck Innovation GmbH to combat neurodegenerative diseases and on the closing of a EUR 12 million Series A financing round, led by the Massa Investment AG, Switzerland.
  • Advised Hitachi Chemical Company, Ltd., a leading manufacturer of functional materials and advanced components with a strong portfolio in the life sciences industry, on the takeover of German apceth Biopharma, a contract development and manufacturing organization for complex cell-based regenerative gene therapy products.


  • Germany (2018)


  • Higher Regional Court of Hamburg (Assessor Exam) (2018)
  • University of Munich (Legal Clerk Exam) (2013)
  • Qingdao University (2011)
  • University of Salamanca (2011)


  • English
  • German
  • Spanish